Blood Testing for Organ Injury from Covid-19
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read More
Search Results for: lung cancer
Better Controls for Covid-19 Diagnostics
Engineered recombinant antibodies offer advantages over serum-based controls.
Read More
FDA Approves FoundationOne CDx as Companion Diagnostic to Detect NTRK Fusions Across All Solid Tumors
The tissue-based comprehensive genomic profiling test is currently approved as a companion diagnostic for more than 20 targeted therapies.
Read More
InterVenn Biosciences IDs Potential Covid-19 Susceptibility Markers
The study demonstrates differential glycoproteomic profiles among covid-19-symptomatic and asymptomatic patients.
Read More
Detecting Varicella-Zoster Virus
A new identification reagent speeds diagnoses of chickenpox and shingles.
Read More